WCN26-2213 COLLAPSING GLOMERULOPATHY DRIVEN BY ABERRANT ACTIVATION OF ERK1/2

Read full text Summarise with VIRAT
Authors: Takuya Morinishi, Ryo Yamada, Keisuke Morita, Ryo Konishi, Yohei Iwashige, Koji Muro, Shigenori Yamamoto, Shinya Yamamoto, Yasuhiro Yamada, Motoko Yanagita
Cited by: 0

Summary

No summary yet. VIRAT can read this paper and write a plain-language summary of its aim, methods, key findings and limitations.

Summarise with VIRAT Free to try with your Science Catalogs account.

Abstract

Collapsing glomerulopathy is associated with a poor prognosis, its pathophysiology remains inadequately understood, and available treatment options are limited. Phosphorylation of ERK1/2 (p-ERK1/2) has been suggested to play a role in podocyte injury; however, previous evidence originates from in vitro studies, leaving the role of p-ERK1/2 in podocytes in vivo insufficiently elucidated.

Fields of Study & Subjects

Renal Diseases and Glomerulopathies Vasculitis and related conditions Chronic Kidney Disease and Diabetes

Publication details

Journal / source
Kidney International Reports
Volume
11
Issue
4
Pages
103871–103871
Publication date
25 March 2026
Language
EN